Javascript must be enabled to continue!
Naloxone Improves Splanchnic Perfusion in Conscious Dogs through Effects on the Central Nervous System
View through CrossRef
Background
In patients undergoing colonoscopy, naloxone has vasodilative properties. However, it remains unclear whether this effect is mediated by central or peripheral mechanisms. The aim of this study was to investigate whether these effects are mediated by an effect of naloxone on the central nervous system.
Methods
Twenty dogs were chronically instrumented for measurement of hemodynamic parameters. Splanchnic blood flow was determined using colored microspheres. Transthoracic echocardiographic examinations were performed to measure cardiac output. In each animal, two experiments were performed in a random order: experiment 1 was determination of splanchnic blood flow before and 5 min after intravenous administration of naloxone (63 microg/kg), and experiment 2 was determination of splanchnic blood flow before and 5 min after administration of naloxone methiodide (63 microg/kg), which does not cross the blood-brain barrier.
Results
Naloxone, but not naloxone methiodide, significantly increased blood flow to the stomach (from 0.41 +/- 0.022 to 0.9 +/- 0.016# ml x g (-1) x min(-1) with naloxone), jejunum (from 0.31 +/- 0.024 to 0.83 +/- 0.083# ml x g(-1) x min(-1) with naloxone), colon (from 0.41 +/- 0.057 to 0.68 +/- 0.008# ml x g(-1) x min(-1) with naloxone), spleen (from 1.45 +/- 0.21 to 2.13 +/- 0.25# ml x g(-1) x min(-1) with naloxone), pancreas (from 0.97 +/- 0.021 to 1.25 +/- 0.005# ml x g(-1) x min(-1) with naloxone), and kidneys (from 3.24 +/- 0.108 to 5.31 +/- 0.26# ml x g(-1) x min(-1) with naloxone), without altering cardiac output or arterial blood pressure in conscious dogs. There were no differences in the hemodynamics or cardiac output between the two experiments. Data are presented as mean +/- SD.
Conclusions
The increased splanchnic perfusion after naloxone is not caused by direct peripheral vascular effects or increased cardiac output. Indirect vasodilative effects on splanchnic vessels mediated by actions of naloxone on the central nervous system account for the increased gastrointestinal perfusion after naloxone in dogs.
Ovid Technologies (Wolters Kluwer Health)
Title: Naloxone Improves Splanchnic Perfusion in Conscious Dogs through Effects on the Central Nervous System
Description:
Background
In patients undergoing colonoscopy, naloxone has vasodilative properties.
However, it remains unclear whether this effect is mediated by central or peripheral mechanisms.
The aim of this study was to investigate whether these effects are mediated by an effect of naloxone on the central nervous system.
Methods
Twenty dogs were chronically instrumented for measurement of hemodynamic parameters.
Splanchnic blood flow was determined using colored microspheres.
Transthoracic echocardiographic examinations were performed to measure cardiac output.
In each animal, two experiments were performed in a random order: experiment 1 was determination of splanchnic blood flow before and 5 min after intravenous administration of naloxone (63 microg/kg), and experiment 2 was determination of splanchnic blood flow before and 5 min after administration of naloxone methiodide (63 microg/kg), which does not cross the blood-brain barrier.
Results
Naloxone, but not naloxone methiodide, significantly increased blood flow to the stomach (from 0.
41 +/- 0.
022 to 0.
9 +/- 0.
016# ml x g (-1) x min(-1) with naloxone), jejunum (from 0.
31 +/- 0.
024 to 0.
83 +/- 0.
083# ml x g(-1) x min(-1) with naloxone), colon (from 0.
41 +/- 0.
057 to 0.
68 +/- 0.
008# ml x g(-1) x min(-1) with naloxone), spleen (from 1.
45 +/- 0.
21 to 2.
13 +/- 0.
25# ml x g(-1) x min(-1) with naloxone), pancreas (from 0.
97 +/- 0.
021 to 1.
25 +/- 0.
005# ml x g(-1) x min(-1) with naloxone), and kidneys (from 3.
24 +/- 0.
108 to 5.
31 +/- 0.
26# ml x g(-1) x min(-1) with naloxone), without altering cardiac output or arterial blood pressure in conscious dogs.
There were no differences in the hemodynamics or cardiac output between the two experiments.
Data are presented as mean +/- SD.
Conclusions
The increased splanchnic perfusion after naloxone is not caused by direct peripheral vascular effects or increased cardiac output.
Indirect vasodilative effects on splanchnic vessels mediated by actions of naloxone on the central nervous system account for the increased gastrointestinal perfusion after naloxone in dogs.
Related Results
Naloxone Use for Opioid Reversal in Patients with Sickle Cell Disease
Naloxone Use for Opioid Reversal in Patients with Sickle Cell Disease
Abstract
Patients with sickle cell disease (SCD) are known to require increased dosing of drugs including opioids due to differences in renal and hepatic metabolism....
Naloxone Knowledge, Carrying, Purchase, and Use
Naloxone Knowledge, Carrying, Purchase, and Use
ImportanceWidespread naloxone access is a key policy response to the opioid crisis. Naloxone availability is typically estimated from pharmacy sales, which exclude naloxone provide...
EPD Electronic Pathogen Detection v1
EPD Electronic Pathogen Detection v1
Electronic pathogen detection (EPD) is a non - invasive, rapid, affordable, point- of- care test, for Covid 19 resulting from infection with SARS-CoV-2 virus. EPD scanning techno...
Abuse deterrence testing: A dose ratio escalation study examining naloxone coadministered with intravenous hydromorphone in non-treatment-seeking, opioid-dependent drug users
Abuse deterrence testing: A dose ratio escalation study examining naloxone coadministered with intravenous hydromorphone in non-treatment-seeking, opioid-dependent drug users
Objective: To assess the reduction in intravenous (IV) abuse potential of hydromorphone from different dose ratio combinations with naloxone in opioid-dependent drug users.Design: ...
Pharmacists’ naloxone offering and dispensing practices
Pharmacists’ naloxone offering and dispensing practices
Objective: The primary objective of this paper is to understand pharmacists’ naloxone offering and dispensing practices and factors affecting those practices. The secondary objecti...
Analgesic efficacy of intravenous naloxone for the treatment of postoperative pruritus: A meta-analysis
Analgesic efficacy of intravenous naloxone for the treatment of postoperative pruritus: A meta-analysis
Objectives: Pruritus may be a significant problem for patients in the postoperative period. There are many options for the treatment of pruritus including intravenous (IV) naloxone...
Improving harm reduction with a naloxone intervention in primary care to prescribe and educate a support person
Improving harm reduction with a naloxone intervention in primary care to prescribe and educate a support person
Objective: To determine whether a pharmacist-led intervention would increase the number of naloxone prescriptions and naloxone administration education in a primary care family med...
Comparing the safety and efficacy of intravenous naloxone administration in opioid-naive and opioid-tolerant hospitalized oncology patients
Comparing the safety and efficacy of intravenous naloxone administration in opioid-naive and opioid-tolerant hospitalized oncology patients
Objective: To compare naloxone doses and clinical outcomes after emergency opioid reversal in opioid-naïve and opioid-tolerant inpatients.Design: Cross-sectional, retrospective cha...

